4.7 Article

Genetic Moderation of the Association of & beta;-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease

Nicolai Franzmeier et al.

Summary: The BDNFVal66Met mutation in Alzheimer's disease is associated with a greater impact on cognitive impairment, particularly through a decrease in hippocampal-medial-frontal connectivity. This finding was consistent across ADAD patients and elderly individuals with sporadically occurring Aβ, and was linked to lower global cognitive performance.

MOLECULAR PSYCHIATRY (2021)

Article Clinical Neurology

Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment

Philip S. Insel et al.

Summary: Carrying the epsilon 2 allele can reduce beta-amyloid accumulation in the presence of the epsilon 4 allele. This protective outcome may be crucial for the development of potential Alzheimer's disease treatments.

JAMA NEUROLOGY (2021)

Article Neurosciences

Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer's pathophysiology

Vijay K. Ramanan et al.

Summary: This study identified a novel genetic factor associated with brain amyloidosis that may influence differential cognitive resilience. These findings provide insight into the underlying biological mechanisms affecting cognitive resilience.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

Itziar de Rojas et al.

Summary: This study identified 6 new genetic variants associated with Alzheimer's disease risk through a large-scale genetic association study. It also demonstrated the efficacy of a polygenic risk score in stratifying individuals at high risk of Alzheimer's disease, providing important data support for further research and preventive treatment of the disease.

NATURE COMMUNICATIONS (2021)

Article Medicine, General & Internal

Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults

Philip S. Insel et al.

Summary: In older cognitively unimpaired adults, there is an association between nighttime sleep duration and regional Aβ pathology, with increased nighttime sleep duration linked to reduced Aβ standardized uptake value ratio. Daytime sleep may be associated with an increased risk for early Aβ accumulation, but does not compensate for the loss of nighttime sleep, demonstrating a circadian rhythm dependence of sleep in preventing Aβ accumulation.

JAMA NETWORK OPEN (2021)

Article Clinical Neurology

Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals

Reisa A. Sperling et al.

JAMA NEUROLOGY (2020)

Article Clinical Neurology

The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults

Philip S. Insel et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Article Clinical Neurology

Determining clinically meaningful decline in preclinical Alzheimer disease

Philip S. Insel et al.

NEUROLOGY (2019)

Article Biochemistry & Molecular Biology

Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease

T. Roostaei et al.

MOLECULAR PSYCHIATRY (2017)

Article Medicine, General & Internal

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

Michael C. Donohue et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Clinical Neurology

Polygenic risk of Alzheimer disease is associated with early- and late-life processes

Elizabeth C. Mormino et al.

NEUROLOGY (2016)

Article Biochemistry & Molecular Biology

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease

Y. Y. Lim et al.

MOLECULAR PSYCHIATRY (2015)

Editorial Material Cell Biology

The A4 Study: Stopping AD Before Symptoms Begin?

Reisa A. Sperling et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Cell Biology

Life Extension Factor Klotho Enhances Cognition

Dena B. Dubal et al.

CELL REPORTS (2014)

Article Clinical Neurology

The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline

Michael C. Donohue et al.

JAMA NEUROLOGY (2014)

Article Clinical Neurology

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

Susan M. Landau et al.

ANNALS OF NEUROLOGY (2012)

Meeting Abstract Radiology, Nuclear Medicine & Medical Imaging

Translational studies with [11C] MK-3168, a PET tracer for fatty acid amide hydrolase (FAAH)

Aniket Joshi et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects

Abhinay D. Joshi et al.

JOURNAL OF NUCLEAR MEDICINE (2012)

Article Biochemistry & Molecular Biology

Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer's disease

S. J. Furney et al.

MOLECULAR PSYCHIATRY (2011)

Article Biochemical Research Methods

Data quality control in genetic case-control association studies

Carl A. Anderson et al.

NATURE PROTOCOLS (2010)

Review Clinical Neurology

Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

Peter T. Nelson et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)

Article Medicine, General & Internal

Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect

Richard J. Caselli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Radiology, Nuclear Medicine & Medical Imaging

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods

Clifford R. Jack et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)